The Inflammation-Based Glasgow Prognostic Score as a Prognostic Factor in Patients with Intensive Cardiovascular Care Unit
Abstract
:1. Introduction
2. Material and Methods
2.1. Subject Selection
2.2. Definitions
2.3. Statistical Examinations
3. Results
4. Discussion
Limitations
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Conflicts of Interest
References
- Piepoli, M.F.; Hoes, A.W.; Agewall, S.; Albus, C.; Brotons, C.; Catapano, A.L.; Cooney, M.T.; Corrà, U.; Cosyns, B.; Deaton, C.; et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur. Heart J. 2016, 37, 2315–2381. [Google Scholar]
- Ibanez, B.; James, S.; Agewall, S.; Antunes, M.J.; Bucciarelli-Ducci, C.; Bueno, H.; Caforio, A.L.P.; Crea, F.; Goudevenos, J.A.; Halvorsen, S.; et al. ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart J. 2018, 39, 119–177. [Google Scholar] [PubMed]
- Ponikowski, P.; Voors, A.A.; Anker, S.D.; Bueno, H.; Cleland, J.G.F.; Coats, A.J.S.; Falk, V.; González-Juanatey, J.R.; Harjola, V.P.; Jankowska, E.A.; et al. ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 2016, 37, 2129–2200. [Google Scholar] [PubMed]
- Wong, B.W.; Meredith, A.; Lin, D.; McManus, B.M. The biological role of inflammation in atherosclerosis. Can. J. Cardiol. 2012, 28, 631–641. [Google Scholar] [CrossRef]
- Lindahl, B.; Toss, H.; Siegbahn, A.; Venge, P.; Wallentin, L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N. Engl. J. Med. 2000, 343, 1139–1147. [Google Scholar] [CrossRef]
- Milo-Cotter, O.; Cotter-Davison, B.; Lombardi, C.; Sun, H.; Bettari, L.; Bugatti, S.; Rund, M.; Metra, M.; Kaluski, E.; Kobrin, I.; et al. Neurohormonal activation in acute heart failure: Results from VERITAS. Cardiology 2011, 119, 96–105. [Google Scholar] [CrossRef] [PubMed]
- Li, J.; Solus, J.; Chen, Q.; Rho, Y.H.; Milne, G.; Stein, C.M.; Darbar, D. Role of inflammation and oxidative stress in atrial fibrillation. Heart Rhythm 2010, 7, 438–444. [Google Scholar] [CrossRef] [PubMed]
- Keskin, M.; Hayiroglu, M.I.; Keskin, T.; Kaya, A.; Tatlısu, M.A.; Altay, S.; Uzun, A.O.; Börklü, E.B.; Güvenç, T.S.; Avcı, I.I.; et al. A novel and useful predictive indicator of prognosis inST-segment elevation myocardial infarction, the prognostic nutritional index. Nutr. Metab. Cardiovasc. Dis. 2017, 27, 438–446. [Google Scholar] [CrossRef]
- Balkwill, F.; Mantovani, A. Inflammation and cancer: Back to Virchow? Lancet 2001, 357, 539–545. [Google Scholar] [CrossRef]
- Coussens, L.M.; Werb, Z. Inflammation and cancer. Nature 2002, 420, 860–867. [Google Scholar] [CrossRef]
- Levey, A.S.; Bosch, J.P.; Lewis, J.B.; Greene, T.; Rogers, N.; Roth, D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann. Intern. Med. 1999, 130, 461–470. [Google Scholar] [CrossRef]
- Thygesen, K.; Alpert, J.S.; Jaffe, A.S.; Chaitman, B.R.; Bax, J.J.; Morrow, D.A.; White, H.D. Fourth Universal Definition of Myocardial Infarction. Glob. Heart. 2018, 13, 305–338. [Google Scholar] [CrossRef] [PubMed]
- American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012, 35, 64–71. [Google Scholar] [CrossRef] [PubMed]
- Tsutamoto, T.; Hisanaga, T.; Wada, A.; Maeda, K.; Ohnishi, M.; Fukai, D.; Mabuchi, N.; Sawaki, M.; Kinoshita, M. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J. Am. Coll. Cardiol. 1998, 31, 391–398. [Google Scholar] [PubMed]
- Altay, S.; Çakmak, H.A.; Öz, T.K.; Karadeniz, F.O.; Türer, A.; Erer, H.B.; Kılıç, G.F.; Keleş, İ.; Can, G.; Eren, M. Long-term prognostic significance of pentraxin-3 in patients with acute myocardial infarction: 5-year prospective cohort study. Anatol. J. Cardiol. 2017, 17, 202–209. [Google Scholar] [CrossRef] [PubMed]
- Çiçek, G.; Açıkgoz, S.K.; Bozbay, M.; Altay, S.; Uğur, M.; Uluganyan, M.; Uyarel, H. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio combination can predict prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Angiology 2015, 66, 441–447. [Google Scholar] [CrossRef]
- Troppan, K.T.; Schlick, K.; Deutsch, A.; Melchardt, T.; Egle, A.; Stojakovic, T.; Beham-Schmid, C.; Weiss, L.; Neureiter, D.; Wenzl, K.; et al. C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients. Br. J. Cancer 2014, 111, 5560. [Google Scholar] [CrossRef]
- Wei, X.; Huang, F.; Wei, Y.; Jing, H.; Xie, M.; Hao, X.; Feng, R. Low lymphocyte-to-monocyte ratio predicts unfavorable prognosis in non-germinal center type diffuse large B-cell lymphoma. Leukç Res. 2014, 38, 694–698. [Google Scholar] [CrossRef] [PubMed]
- Altay, S.; Onat, A.; Kaya, A. Shared underlying dynamics between heart failure and cancer: Autoimmune activation? Eur. J. Heart Fail. 2016, 18, 877. [Google Scholar] [CrossRef]
- Chojkier, M. Inhibition of albumin synthesis in chronic diseases: Molecular mechanisms. J. Clin. Gastroenterol. 2005, 39, 143–146. [Google Scholar] [CrossRef]
- Don, B.R.; Kaysen, G. Serum albumin: Relationship to inflammation and nutrition. Semin. Dial. 2004, 17, 432–437. [Google Scholar] [CrossRef] [PubMed]
- Gupta, D.; Lis, C.G. Pretreatment serum albumin as a predictor of cancer survival: A systematic reviewof the epidemiological literature. Nutr. J. 2010, 9, 69. [Google Scholar] [CrossRef] [PubMed]
- Moujaess, E.; Fakhoury, M.; Assi, T.; Elias, H.; El Karak, F.; Ghosn, M.; Katta, J. The Therapeutic use of human albumin in cancer patients’ management. Crit. Rev. Oncol. Hematol. 2017, 120, 203–209. [Google Scholar] [CrossRef] [PubMed]
- Bonilla-Palomas, J.L.; Gamez-Lopez, A.L.; Moreno-Conde, M.; López-Ibáñez, M.C.; Anguita-Sánchez, M.; de la Sacristana, A.G.; García-Catalán, F.; Villar-Ráez, A. Hypoalbuminaemia in acute heart failure patients: Causes and its impact on hospital and long-term mortality. J. Card. Fail. 2014, 20, 350–358. [Google Scholar] [CrossRef] [PubMed]
- Uthamalingam, S.; Kandala, J.; Daley, M.; Patvardhan, E.; Capodilupo, R.; Moore, S.A.; Januzzi, J.L. Serum albumin and mortality inacutely decompensated heart failure. Am. Heart J. 2010, 160, 1149–1155. [Google Scholar] [CrossRef] [PubMed]
- Al-Azzawi, H.F.; Obi, O.C.; Safi, J.; Song, M. Nephrotic syndrome-induced thromboembolism in adults. Int. J. Crit. Illn. Inj. Sci. 2016, 6, 85–88. [Google Scholar] [CrossRef] [PubMed]
- Nishida, T.; Nakamura, K.; Haraga, J.; Ogawa, C.; Kusumoto, T.; Seki, N.; Masuyama, H.; Katayama, N.; Kanazawa, S.; Hiramatsu, Y. The Glasgow Prognostic Score Determined During Concurrent Chemoradiotherapy Is an Independent Predictor of Survival for Cervical Cancer. Int. J. Gynecol. Cancer 2015, 25, 1306–1314. [Google Scholar] [CrossRef] [PubMed]
- Yotsukura, M.; Ohtsuka, T.; Kaseda, K.; Kamiyama, I.; Hayashi, Y.; Asamura, H. Value of the Glasgow Prognostic Score as a Prognostic Factor in Resectable Non-Small Cell Lung Cancer. J. Thorac. Oncol. 2016, 11, 1311–1318. [Google Scholar] [CrossRef] [PubMed]
- Petrelli, F.; Barni, S.; Coinu, A.; Bertocchi, P.; Borgonovo, K.; Cabiddu, M.; Ghilardi, M.; Zaniboni, A. The Modified Glasgow Prognostic Score and Survival in Colorectal Cancer: A Pooled Analysis of the Literature. Rev. Recent Clin. Trials 2015, 10, 135–141. [Google Scholar] [CrossRef]
- Hao, X.; Wei, Y.; Wei, X.; Zhou, L.; Wei, Q.; Zhang, Y.; Huang, W.; Feng, R. Glasgow prognostic score is superior to other inflammation-based scores in predicting survival of diffuse large B-cell lymphoma. Oncotarget 2017, 8, 76740–76748. [Google Scholar] [CrossRef]
- Petrella, F.; Radice, D.; Casiraghi, M.; Gasparri, R.; Borri, A.; Guarize, J.; Galetta, D.; Venturino, M.; Spaggiari, L. Glasgow Prognostic Score Class 2 Predicts Prolonged Intensive Care Unit Stay in Patients Undergoing Pneumonectomy. Ann. Thorac. Surg. 2016, 102, 1898–1904. [Google Scholar] [CrossRef] [PubMed]
- Kang, H.S.; Cho, K.W.; Kwon, S.S.; Kim, Y.H. Prognostic significance of Glasgow prognostic score in patients with acute exacerbation of idiopathic pulmonary fibrosis. Respirology 2018, 23, 206–212. [Google Scholar] [CrossRef] [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Altay, S.; Gürdoğan, M.; Keskin, M.; Kardaş, F.; Çakır, B. The Inflammation-Based Glasgow Prognostic Score as a Prognostic Factor in Patients with Intensive Cardiovascular Care Unit. Medicina 2019, 55, 139. https://doi.org/10.3390/medicina55050139
Altay S, Gürdoğan M, Keskin M, Kardaş F, Çakır B. The Inflammation-Based Glasgow Prognostic Score as a Prognostic Factor in Patients with Intensive Cardiovascular Care Unit. Medicina. 2019; 55(5):139. https://doi.org/10.3390/medicina55050139
Chicago/Turabian StyleAltay, Servet, Muhammet Gürdoğan, Muhammed Keskin, Fatih Kardaş, and Burcu Çakır. 2019. "The Inflammation-Based Glasgow Prognostic Score as a Prognostic Factor in Patients with Intensive Cardiovascular Care Unit" Medicina 55, no. 5: 139. https://doi.org/10.3390/medicina55050139